Morningstar Releases Eighth Annual Study on Advancements and Opportunities in Health Savings Account Industry
Morningstar has released its eighth annual study on Health Savings Accounts (HSAs), evaluating 11 top providers for both investment and spending use cases. The study reveals significant improvements in HSA features, including lower fees and better investment options. However, only four providers received an Above Average or better rating for both use cases.
Key findings include:
- Total HSA assets reached $123 billion in 2023
- Fidelity leads providers with a High assessment for both spending and savings accounts
- HSA contribution limits are set to increase in 2025
- Providers' investment menus are strong, with at least 89% of each lineup consisting of funds with Gold, Silver, or Bronze Morningstar Medalist Ratings
The study emphasizes the need for improved transparency and participant awareness to maximize HSA potential.
Morningstar ha pubblicato il suo ottavo studio annuale sui Conti di Risparmio per la Salute (HSA), valutando 11 principali fornitori sia per le caratteristiche di investimento che di spesa. Lo studio rivela significativi miglioramenti nelle funzionalità degli HSA, inclusi costi inferiori e migliori opzioni di investimento. Tuttavia, solo quattro fornitori hanno ricevuto una valutazione superiore alla media o migliore per entrambi i casi d'uso.
I risultati chiave includono:
- Le attività totali degli HSA hanno raggiunto $123 miliardi nel 2023
- Fidelity è in testa tra i fornitori con una valutazione alta sia per i conti di spesa che per quelli di risparmio
- I limiti di contribuzione agli HSA sono destinati ad aumentare nel 2025
- I menu di investimento dei fornitori sono solidi, con almeno il 89% di ogni gamma composto da fondi con Medaglie Morningstar di Oro, Argento o Bronzo
Lo studio sottolinea la necessità di una maggiore trasparenza e consapevolezza da parte dei partecipanti per massimizzare il potenziale degli HSA.
Morningstar ha publicado su octavo estudio anual sobre Cuentas de Ahorro para la Salud (HSA), evaluando a 11 principales proveedores tanto para casos de uso de inversión como de gasto. El estudio revela mejoras significativas en las características de las HSA, incluyendo tarifas más bajas y mejores opciones de inversión. Sin embargo, solo cuatro proveedores recibieron una calificación de Superior a la Media o mejor en ambos casos de uso.
Los hallazgos clave incluyen:
- Los activos totales de las HSA alcanzaron $123 mil millones en 2023
- Fidelity lidera entre los proveedores con una evaluación Alta tanto para cuentas de gasto como de ahorro
- Los límites de contribución a las HSA están destinados a aumentar en 2025
- Los menús de inversión de los proveedores son sólidos, con al menos el 89% de cada línea compuesta por fondos con Medallas Morningstar de Oro, Plata o Bronce
El estudio enfatiza la necesidad de una mayor transparencia y conciencia de los participantes para maximizar el potencial de las HSA.
모닝스타는 건강 저축 계좌 (HSA)에 대한 제8회 연례 연구를 발표하며, 11개의 주요 제공업체를 투자 및 지출 사용 사례에 대해 평가했습니다. 연구 결과, HSA 기능에서 수수료 인하 및 더 나은 투자 옵션 등 상당한 개선이 있음을 보여줍니다. 그러나 네 곳의 제공업체만이 두 가지 사용 사례 모두에서 평균 이상 또는 그 이상의 평가를 받았습니다.
주요 발견 사항은 다음과 같습니다:
- 2023년 HSA 총 자산은 1230억 달러에 도달했습니다
- 피델리티는 지출 및 저축 계좌 모두에 대해 높은 평가를 받은 제공업체입니다
- HSA 기부 한도는 2025년에 증가할 예정입니다
- 제공업체의 투자 메뉴는 강력하여 각 라인업의 최소 89%가 골드, 실버 또는 브론즈 모닝스타 메달 평가를 받은 펀드로 구성됩니다
이 연구는 HSA 잠재력을 극대화하기 위한 향상된 투명성과 참가자 인식의 필요성을 강조합니다.
Morningstar a publié sa huitième étude annuelle sur les Comptes d'Épargne Santé (HSA), évaluant 11 principaux fournisseurs pour les cas d'utilisation d'investissement et d'utilisation. L'étude révèle des améliorations significatives des fonctionnalités des HSA, notamment des frais réduits et de meilleures options d'investissement. Cependant, seuls quatre fournisseurs ont reçu une note au-dessus de la moyenne ou meilleure pour les deux cas d'utilisation.
Les résultats clés incluent :
- Les actifs totaux des HSA ont atteint 123 milliards de dollars en 2023
- Fidelity est en tête des fournisseurs avec une évaluation élevée tant pour les comptes de dépenses que de savings
- Les limites de contribution aux HSA devraient augmenter en 2025
- Les menus d'investissement des fournisseurs sont solides, avec au moins 89 % de chaque gamme composée de fonds ayant des Médailles Morningstar d'Or, d'Argent ou de Bronze
L'étude souligne la nécessité d'une meilleure transparence et d'une sensibilisation des participants pour maximiser le potentiel des HSA.
Morningstar hat seine achte jährliche Studie zu Gesundheitssparkonten (HSAs) veröffentlicht, in der 11 führende Anbieter sowohl für Investitions- als auch für Ausgabefälle bewertet werden. Die Studie zeigt bedeutende Verbesserungen bei den HSA-Funktionen, einschließlich niedrigerer Gebühren und besserer Investitionsmöglichkeiten. Allerdings haben nur vier Anbieter eine überdurchschnittliche oder bessere Bewertung für beide Anwendungsfälle erhalten.
Wichtige Ergebnisse umfassen:
- Die Gesamtanlagen der HSAs erreichten 123 Milliarden Dollar im Jahr 2023
- Fidelity führt die Anbieter mit einer hohen Bewertung sowohl für Ausgaben- als auch für Sparkonten an
- Die Beitragsgrenzen für HSAs sollen im Jahr 2025 erhöht werden
- Die Investitionsmenüs der Anbieter sind stark, wobei mindestens 89 % jeder Reihe aus Fonds mit Gold-, Silber- oder Bronze-Morningstar-Medaillenbewertungen bestehen
Die Studie betont die Notwendigkeit einer verbesserten Transparenz und Teilnehmerbewusstsein, um das Potenzial der HSAs zu maximieren.
- Total HSA assets reached $123 billion in 2023, showing strong growth
- Fidelity offers a high 2.69% interest rate on all balances, outperforming competitors
- HSA contribution limits are set to increase in 2025, enhancing tax advantages
- At least 89% of each provider's investment lineup consists of highly-rated funds
- Four providers received Above Average or better ratings for both investment and spending use cases
- Only four out of eleven providers received Above Average or better ratings for both use cases
- Transparency issues and hidden costs continue to pose challenges for investors
- Many providers impose minimum account balance requirements before allowing investments
- Automatic enrollment in HSAs is not permitted by the government, unlike retirement plans
Insights
The release of Morningstar's eighth annual HSA study highlights significant growth and improvements in the HSA industry, which could have positive implications for MORN's business. The study's findings of total HSA assets reaching
Morningstar's role in assessing HSA providers positions them as a key authority in this growing financial sector. This could lead to increased recognition and potentially more business opportunities in the HSA space. The comprehensive nature of the study, covering 11 top HSA providers, demonstrates Morningstar's extensive reach and expertise in this area.
The inclusion of a new provider, NueSynergy, in the study shows Morningstar's ability to adapt to market changes and maintain relevance. This adaptability is important for maintaining their position as a leading provider of independent investment insights.
While this news doesn't directly impact Morningstar's financials, it reinforces their brand as a trusted source of financial analysis, which could indirectly contribute to long-term growth and stability in their core business of providing investment research and tools.
The HSA industry's growth trajectory presents a significant opportunity for Morningstar to expand its influence and revenue streams. With HSA assets surging to
The study's findings on provider improvements, such as lower fees and better investment options, indicate a maturing market. This maturation could lead to more sophisticated products and services, potentially increasing demand for Morningstar's expertise in evaluating and comparing these offerings.
The highlighted areas for improvement, such as transparency issues and hidden costs, present opportunities for Morningstar to further establish itself as an advocate for investors. By addressing these challenges in their research, they can enhance their value proposition to both individual investors and institutional clients.
The potential legislative changes mentioned, such as increased contribution limits and new rollover options, could further accelerate HSA adoption. This would likely increase the importance of Morningstar's HSA research, potentially leading to higher demand for their services and strengthening their market position.
Assessments of the leading providers highlight continued progress and identify areas for significant improvement
Overall, the study found meaningful improvements in HSA features, such as lower fees and better investment options. However, Morningstar highlights substantial room for growth in the industry, with just four providers receiving an Above Average or better rating on both evaluated use cases.
"Efforts by providers to enhance HSA offerings have proven beneficial for investors," said Greg Carlson, senior manager research analyst. "Nonetheless, transparency issues, including hidden costs, continue to pose challenges for investors as they navigate their healthcare finances. Our study underscores the progress made while highlighting the hurdles that need to be addressed for HSAs to achieve their full potential."
Highlights from the study include:
-
Total assets in HSAs soared to
in 2023, maintaining their strong growth trajectory. This growth is driven by the increased prevalence of high-deductible health plans (HDHPs) since HSAs were introduced.$123 billion -
Fidelity continues to lead among providers, earning a High assessment for both its spending account and savings account features. Notably, it offers an interest rate of
2.69% on all balances, far surpassing other providers, none of which offer more than1% on any balance level. - HSA contribution limits are set to rise in 2025, bolstering their already outstanding tax advantages, which are superior to 401(k)s, IRAs, and 529 plans. Proposed legislation would also allow individuals to contribute to an HSA even if their spouse uses a flexible spending account (FSA) and enable certain fund rollovers from FSAs into HSAs.
- Providers and regulators could improve participant awareness and simplify processes to increase engagement in HSA features. For instance, unlike retirement plans, automatic enrollment in HSAs is not permitted by the government. Furthermore, many providers impose minimum account balance requirements before participants can invest.
- From 2019 to 2022, several acquisitions among key players in the space led to significant consolidation among HSA providers. Recently, the pace of such deals has slowed, marking a noteworthy shift in the industry landscape.
-
Providers' investment menus are strong, as evidenced by the Morningstar Medalist Rating. At least
89% of each lineup consists of funds with Gold, Silver, or Bronze ratings.
The overall assessment of each HSA provider is listed below.
HSA Provider
|
Overall Assessment as Investing Account |
Overall Assessment as Spending Account |
Associated Bank |
Average |
Average |
Bank of America |
Average |
Below Average |
Fidelity |
High |
High |
First American Bank |
Average |
Above Average |
HealthEquity |
Above Average |
Above Average |
HSA Bank* |
Above Average |
Above Average |
Lively |
Average |
Above Average |
NueSynergy |
Above Average |
Average |
Optum |
Average |
Below Average |
Saturna |
Above Average |
Above Average |
UMB |
Average |
Above Average |
*HSA Bank is Morningstar, Inc.’s HSA plan provider. |
This year's study included one new addition: NueSynergy, a business service provider that is expanding the reach of its HSA offerings to a national level. Morningstar does not assess HSAs offered by employers, as details can vary depending on relationships and headcount.
Click here to read the HSA Landscape Report, which includes complete assessments for the 11 providers and methodology. An article on Morningstar.com summarizing the report’s findings is available here.
About Morningstar, Inc.
Morningstar, Inc. is a leading provider of independent investment insights in
Morningstar’s Manager Research Group
Morningstar’s Manager Research Group consists of various wholly owned subsidiaries of Morningstar, Inc. including, but not limited to, Morningstar Research Services LLC. Morningstar Manager Research provides independent, fundamental analysis on managed investment strategies. Morningstar views are expressed in the form of Morningstar Medalist Ratings, which are derived through research of three key pillars—People, Process, and Parent. The Morningstar Medalist Rating is the summary expression of Morningstar’s forward-looking analysis of investment strategies as offered via specific vehicles using a rating scale of Gold, Silver, Bronze, Neutral, and Negative. A global research team issues detailed research reports on strategies that span vehicle, asset class, and geography.
Medalist Ratings are not statements of fact, nor are they credit or risk ratings, and should not be used as the sole basis for investment decisions. A Medalist Rating is not intended to be nor is a guarantee of future performance. This press release is for informational purposes only; references to securities should not be considered an offer or solicitation to buy or sell the securities.
©2024 Morningstar, Inc. All Rights Reserved.
MORN-R
View source version on businesswire.com: https://www.businesswire.com/news/home/20240925316030/en/
Morningstar Media Contact:
Michael Claussen, +1 312 696-6037 or newsroom@morningstar.com
Source: Morningstar, Inc.
FAQ
What were the key findings of Morningstar's 2023 HSA study?
How did Fidelity perform in Morningstar's HSA provider assessment?
What improvements and challenges did Morningstar (MORN) identify in the HSA industry?